BMY Exercise Disclosure
Lenkowsky Adam · SEC Form 4 · Filed Nov 4, 2026
Exercise
Calculated transaction value
$0
Lenkowsky Adam EVP, Chief Commercial Officer
BMY
Transaction date
Nov 3, 2026
Public filing date
Nov 4, 2026
Filing lag
Filed 1 day later
BMY daily price context
Close on/before transaction
$61.71
Nov 3, 2026
First close after public filing
$63.13
Nov 5, 2026
Return after filing · so far
-1.57%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock, $0.10 par value
- Quantity / price
- 7,522 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001975719-26-000006
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$237.46K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Bristol Myers Squibb Co BMY Current | Exercise | Nov 3, 2026 | $0 |
| Bristol Myers Squibb Co BMY | Disposition | Nov 3, 2026 | $237.46K |
| Bristol Myers Squibb Co BMY | Exercise | Nov 3, 2026 | $0 |